Alpha Tau reports 100% disease control in pancreatic cancer trials

Go back to Alpha Tau reports 100% disease control in pancreatic cancer trials
(NASDAQ: DRTS) Delayed: 14.11 --0 (-0%)
Previous Close $14.11    52 Week High
Open $14.11    52 Week Low
Day High $14.11    P/E N/A 
Day Low $14.11    EPS
Volume 10       

(NASDAQ: DRTSW) Delayed: 3.60 --0 (-0%)
Previous Close $3.60    52 Week High
Open $3.60    52 Week Low
Day High $3.60    P/E N/A 
Day Low $3.60    EPS
Volume